Skip to content
MS
Single-pathway Pathway metabolite unreviewed

ApoA-I

0
Pathways
0
Categories
0
As substrate
0
As product

Reactions involving ApoA-I

Every recorded step where this molecule takes part

Showing all 1 reactions.

Recent literature

Europe PMC · fetched just now · sorted by publication date

  1. 1
  2. 2
    Tumor microenvironment-responsive conformational activation of apoA-I mimetic peptides for targeted cancer therapy.

    Rui M, Fang L, Jia M, Liang W, Li Y, Ruan Y, Feng C. · 2025-12-17

    cited 1× open access unreviewed
  3. 3
    Edaravone attenuates carbonyl-stress-driven ApoA-I carboxymethylation and macrophage cholesterol-handling dysfunction in diabetic atherosclerosis.

    Ma HC, Xu YX, Zhang ZR, Zhang LF, Zhou XF, Luo HY, Xiong NQ, Song KC, Pu LJ. · 2026-07-30

    unreviewed
  4. 4
    Novel associations of Claudin gene variants with kidney stone disease.

    Liu IY, Haverfield J, MacKenzie E, Dufresne L, Ryan AK, Engert JC, Gupta IR. · 2026-07-16

    open access unreviewed
  5. 5
  6. 6
    COPI Coatomer Regulates Several Steps of HDL Metabolism.

    Panteloglou G, Zanoni P, Law CS, Woods B, Othman A, Yalcinkaya M, Norrelykke SF, Rzepiela AJ, Stoma S, Steble… · 2026-08-13

    unreviewed
  7. 7
    HDL-associated proteins affecting CVD and systemic inflammation.

    Delk SC, Reddy ST. · 2026-08-12

    unreviewed
  8. 8
  9. 9
    Structural Basis for the Pro-amyloidogenic Action and Ligand Binding of a Novel W72R Variant of Human Apolipoprotein A-I.

    Prokaeva T, Jayaraman S, Klimtchuk ES, Libbey C, Mendelson L, Spencer B, Chen H, Van Le NH, Sanchez A, Kelleh… · 2026-06-24

    unreviewed
  10. 10
    Estimating the True MACE Benefits From Tirzepatide in SURPASS-CVOT Using an Imputed Placebo Analysis of REWIND.

    Sattar N, Gerstein HC, D'Alessio D, Bhatt DL, Buse JB, Del Prato S, Kahn SE, Lincoff AM, McGuire DK, Nauck MA… · 2026-10-01

    cited 8× open access unreviewed

External claims. These come from an index outside this database and are not checked against it. Treat them as leads.